🇺🇸 PFE — Pfizer Inc.

Salud Compra
← Volver

Precio actual

29,39 USD

Máx. histórico

61,25

1786 días

Split 1054:1000 del 17/11/2020

Caída desde máximo

-52,02%

Rango 52 semanas

23,62 – 31,44

Variación hoy

-0,20%

Cierre anterior

29,88

Rango de hoy

28,54 – 29,43

Volumen hoy

48.232.765

Peor caída histórica

-69,25%

12/04/1999 → 02/03/2009

Recuperado en 1717 días

Volatilidad anualizada ⓘ

27,33%

Información
Nombre completo
Pfizer Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
75.000
PER ⓘ
41,99 (puede no estar actualizado)
Dividend yield
5,76% (puede no estar actualizado)
Precio objetivo analistas
29,72 USD (puede no estar actualizado)
Primera cotización
01/06/1972
Precio actualizado
hace 2 días
Sobre la empresa

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Dividendos repartidos Total últimos 12 meses: 1,2900 USD · Yield: 4,39%
Fecha de pago Importe por participación
03/08/2011 0,1898 USD
11/05/2011 0,1898 USD
02/02/2011 0,1898 USD
04/11/2010 0,1708 USD
04/08/2010 0,1708 USD
05/05/2010 0,1708 USD
03/02/2010 0,1708 USD
04/11/2009 0,1518 USD
05/08/2009 0,1518 USD
06/05/2009 0,1518 USD
04/02/2009 0,3036 USD
05/11/2008 0,3036 USD
06/08/2008 0,3036 USD
07/05/2008 0,3036 USD
06/02/2008 0,3036 USD
Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2020 1054:1000
01/07/1999 3:1
01/07/1997 2:1
03/07/1995 2:1
01/04/1991 2:1
01/07/1983 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
21/09/2000 38,78 41,57 38,60 40,32 +3,86% 7,65% 13.702.949
20/09/2000 38,84 38,90 38,19 38,83 -0,23% 1,83% 6.889.366
19/09/2000 39,79 39,97 38,72 38,91 -2,20% 3,13% 8.958.895
18/09/2000 39,08 39,85 38,96 39,79 +1,67% 2,28% 7.588.168
15/09/2000 38,90 39,55 38,90 39,14 -0,30% 1,68% 13.858.624
14/09/2000 39,31 39,31 38,72 39,26 +0,76% 1,51% 9.318.309
13/09/2000 39,14 39,43 38,66 38,96 +2,02% 1,97% 10.191.231
12/09/2000 38,19 38,96 37,95 38,19 -1,83% 2,64% 10.886.028
11/09/2000 37,95 38,90 37,65 38,90 +1,23% 3,28% 10.975.302
08/09/2000 38,19 38,54 37,83 38,43 +0,46% 1,86% 11.340.724
07/09/2000 37,83 38,48 37,83 38,25 +1,10% 1,72% 13.816.043
06/09/2000 38,48 38,54 37,36 37,83 -2,30% 3,08% 20.218.039
05/09/2000 40,38 40,56 38,37 38,72 -5,43% 5,43% 20.398.694
01/09/2000 41,51 41,63 40,68 40,95 +0,04% 2,29% 7.893.617
31/08/2000 40,56 41,21 40,38 40,93 +2,72% 2,05% 11.687.384
30/08/2000 40,32 40,62 39,61 39,85 -1,32% 2,50% 9.896.111
29/08/2000 39,97 41,09 39,85 40,38 -0,66% 3,12% 10.246.672
28/08/2000 41,69 41,69 40,56 40,65 -2,21% 2,70% 7.801.813
25/08/2000 41,33 41,69 40,86 41,57 +1,67% 2,01% 5.965.745
24/08/2000 41,15 41,21 40,80 40,89 +0,15% 1,01% 6.424.762
23/08/2000 40,20 41,15 40,20 40,83 +1,25% 2,36% 6.931.631
22/08/2000 41,39 41,39 40,14 40,32 -2,86% 3,01% 9.551.559
21/08/2000 40,74 41,51 39,85 41,51 +2,34% 4,08% 6.738.327
18/08/2000 41,27 41,45 40,14 40,56 -2,84% 3,16% 11.487.441
17/08/2000 41,69 42,34 40,92 41,75 +1,30% 3,41% 12.051.647
16/08/2000 40,74 41,51 40,56 41,21 +3,42% 2,33% 8.243.334
15/08/2000 40,80 41,09 39,85 39,85 -1,68% 3,05% 8.213.295
14/08/2000 40,92 41,09 40,53 40,53 -0,36% 1,38% 7.688.403
11/08/2000 40,68 41,03 40,32 40,68 +2,08% 1,75% 8.070.162
10/08/2000 40,80 41,39 39,85 39,85 -1,75% 3,78% 13.892.563